COVID-19 pandemic in Japan

The disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus Disease-2019 (COVID-19), is a global emergency. The first case of COVID-19 was confirmed in Japan in January 2020, a second outbreak of infection occurred in mid-March and a third peak at the beginnin...

Descripción completa

Detalles Bibliográficos
Autores principales: Amengual, Olga, Atsumi, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671668/
https://www.ncbi.nlm.nih.gov/pubmed/33205224
http://dx.doi.org/10.1007/s00296-020-04744-9
_version_ 1783610970626588672
author Amengual, Olga
Atsumi, Tatsuya
author_facet Amengual, Olga
Atsumi, Tatsuya
author_sort Amengual, Olga
collection PubMed
description The disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus Disease-2019 (COVID-19), is a global emergency. The first case of COVID-19 was confirmed in Japan in January 2020, a second outbreak of infection occurred in mid-March and a third peak at the beginning of August. The COVID-19 phenotype was milder in Japan than in other countries, although the restrictive measures applied in the country have not been as strict as in other places. Factors related to a possible reduced susceptibility to the pulmonary manifestations of SARS-CoV-2 may have contributed to better outcomes and lower mortality in Japan.
format Online
Article
Text
id pubmed-7671668
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-76716682020-11-18 COVID-19 pandemic in Japan Amengual, Olga Atsumi, Tatsuya Rheumatol Int Expert Opinion The disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus Disease-2019 (COVID-19), is a global emergency. The first case of COVID-19 was confirmed in Japan in January 2020, a second outbreak of infection occurred in mid-March and a third peak at the beginning of August. The COVID-19 phenotype was milder in Japan than in other countries, although the restrictive measures applied in the country have not been as strict as in other places. Factors related to a possible reduced susceptibility to the pulmonary manifestations of SARS-CoV-2 may have contributed to better outcomes and lower mortality in Japan. Springer Berlin Heidelberg 2020-11-17 2021 /pmc/articles/PMC7671668/ /pubmed/33205224 http://dx.doi.org/10.1007/s00296-020-04744-9 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Expert Opinion
Amengual, Olga
Atsumi, Tatsuya
COVID-19 pandemic in Japan
title COVID-19 pandemic in Japan
title_full COVID-19 pandemic in Japan
title_fullStr COVID-19 pandemic in Japan
title_full_unstemmed COVID-19 pandemic in Japan
title_short COVID-19 pandemic in Japan
title_sort covid-19 pandemic in japan
topic Expert Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671668/
https://www.ncbi.nlm.nih.gov/pubmed/33205224
http://dx.doi.org/10.1007/s00296-020-04744-9
work_keys_str_mv AT amengualolga covid19pandemicinjapan
AT atsumitatsuya covid19pandemicinjapan

Ejemplares similares